The FDA has declined to authorize the common antidepressant fluvoxamine as a COVID-19 treatment.
Read the full post on Becker's Hospital Review - Healthcare News
FDA rejects antidepressant as COVID-19 treatment: 3 notes
Read the full post on Becker's Hospital Review - Healthcare News